Limitless Life Nootropics vs Peptide Technologies
Independent side-by-side comparison across the 2 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Limitless Life Nootropics
14 peptides covered with 58 lab tests. BPC-157 averages 6.6 across 6 tests with consistency penalty triggered.
Limitless Life Nootropics full review →Peptide Technologies
5 BPC-157 tests with score variance 5.0–10.0. GHK-Cu and Ipamorelin coverage solid.
Peptide Technologies full review →Side-by-side breakdown
| PEPTIDE | LIMITLESS LIFE NOOTROPICS | PEPTIDE TECHNOLOGIES | WINNER |
|---|---|---|---|
| Ipamorelin |
7.2
B (4 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
| GHK-Cu |
6.5
B (5 tests)
|
7.4
B (6 tests)
|
Peptide Technologies |
| BPC-157 |
6.4
B (6 tests)
|
6.5
B (5 tests)
|
Peptide Technologies |
| Semaglutide |
6.4
B (5 tests)
|
—(not sold)
|
Limitless Life Nootropics only |
Which to choose
Across the 2 peptides both vendors sell, Limitless Life Nootropics scores higher on 0, Peptide Technologies scores higher on 1, and 1 are within 0.3 points (effectively tied). Limitless Life Nootropics additionally sells Ipamorelin, Semaglutide; Peptide Technologies does not.
Choose Peptide Technologies for: GHK-Cu.
Either works for BPC-157 — composite scores are within 0.3 points.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Limitless Life Nootropics review · Peptide Technologies review